Mycophenolic acid AUC in Thai kidney transplant recipients receiving low dose mycophenolate and its association withUGT2B7 polymorphisms

Background: Despite use of a lower mycophenolate dose in Thai kidney transplant patients, acceptable graft and patient outcomes can be achieved. We therefore examined the pharmacokinetics of mycophenolic acid (MPA) by area under the curve (AUC) and investigated genetic contribution in mycophenolate...

Full description

Saved in:
Bibliographic Details
Published inPharmacogenomics and personalized medicine Vol. 7; p. 379
Main Authors Pithukpakorn, Manop, Tiwawanwong, Tiwat, Lalerd, Yupaporn, Assawamakin, Anunchai, Premasathian, Nalinee, Tasanarong, Adis, Thongnoppakhun, Wanna, Vongwiwatana, Attapong
Format Journal Article
LanguageEnglish
Published Macclesfield Taylor & Francis Ltd 01.01.2014
Subjects
Chromatography
Deoxyribonucleic acid
DNA
Dosage
Drug dosages
Immunosuppressive agents
Kidney transplants
Medicine
Metabolism
Metabolites
R&D
Research & development
Transplants & implants
Online AccessGet full text

Cover

More Information
Summary:Background: Despite use of a lower mycophenolate dose in Thai kidney transplant patients, acceptable graft and patient outcomes can be achieved. We therefore examined the pharmacokinetics of mycophenolic acid (MPA) by area under the curve (AUC) and investigated genetic contribution in mycophenolate metabolism in this population. Methods: Kidney transplant recipients with stable graft function who were receiving mycophenolate mofetil 1,000 mg/d in combination with either cyclosporine or tacrolimus, and prednisolone were studied. The MPA concentration was measured by fluorescence polarization immunoassay (FPIA), at predose and 1, 1.5, 2, 4, 6, 8, 10, and 12 hours after dosing. Genetic polymorphisms inUGT1A8, UGT1A9, and UGT2B7 were examined by denaturing high-performance liquid chromatography (DHPLC)-based single-base extension (SBE) analysis. Results: A total 138 patients were included in study. The mean AUC was 39.49 mg-h/L (28.39–89.58 mg-h/L), which was in the therapeutic range. The correlation between the predose MPA concentration and AUC was poor. The mean AUC in the tacrolimus group was higher than that in the cyclosporine group. Polymorphisms in UGT2B7 showed significant association with AUC. Conclusion: Most of our patients with reduced mycophenolate dose had the AUC within the therapeutic range. Genetic polymorphisms in UGT2B7may play a role in MPA metabolism in Thai kidney transplant patients.
ISSN:1178-7066
1178-7066
DOI:10.2147/PGPM.S72760